Title of article
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
Author/Authors
David Gilligan، نويسنده , , Marianne Nicolson، نويسنده , , Ian Smith، نويسنده , , Harry Groen، نويسنده , , Otilia Dalesio، نويسنده , , Peter Goldstraw، نويسنده , , Matthew Hatton، نويسنده , , Penelope Hopwood، نويسنده , , Christian Manegold، نويسنده , , Franz Schramel، نويسنده , , Hans Smit، نويسنده , , Jan van Meerbeeck، نويسنده , , Matthew Nankivell، نويسنده , , Mahesh Parmar، نويسنده , , Cheryl Pugh، نويسنده , , Richard Stephens، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
9
From page
1929
To page
1937
Abstract
Summary
Background
Although surgery offers the best chance of cure for patients with non-small cell lung cancer (NSCLC), the overall 5-year survival rate is modest, and improvements are urgently needed. In the 1990s, much interest was generated from two s
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
591455
Link To Document